» Articles » PMID: 18485877

The Epithelial-mesenchymal Transition Generates Cells with Properties of Stem Cells

Abstract

The epithelial-mesenchymal transition (EMT) is a key developmental program that is often activated during cancer invasion and metastasis. We here report that the induction of an EMT in immortalized human mammary epithelial cells (HMLEs) results in the acquisition of mesenchymal traits and in the expression of stem-cell markers. Furthermore, we show that those cells have an increased ability to form mammospheres, a property associated with mammary epithelial stem cells. Independent of this, stem cell-like cells isolated from HMLE cultures form mammospheres and express markers similar to those of HMLEs that have undergone an EMT. Moreover, stem-like cells isolated either from mouse or human mammary glands or mammary carcinomas express EMT markers. Finally, transformed human mammary epithelial cells that have undergone an EMT form mammospheres, soft agar colonies, and tumors more efficiently. These findings illustrate a direct link between the EMT and the gain of epithelial stem cell properties.

Citing Articles

ATXN3 deubiquitinates ZEB1 and facilitates epithelial-mesenchymal transition in glioblastoma.

Wei R, Shi X, Qiu W, Yang M, Chen Y, Song S Sci Rep. 2025; 15(1):7868.

PMID: 40050358 PMC: 11885642. DOI: 10.1038/s41598-025-92317-w.


The role of ESRP1 in solid tumor development through the regulation of CD44 splicing and EMT processes.

Wang L, Zhang M, Zhao K, Yuan X, Zhao H, Liu Y Front Oncol. 2025; 15:1451130.

PMID: 40046628 PMC: 11881191. DOI: 10.3389/fonc.2025.1451130.


Evolutionary fingerprints of epithelial-to-mesenchymal transition.

Perelli L, Zhang L, Mangiameli S, Giannese F, Mahadevan K, Peng F Nature. 2025; .

PMID: 40044861 DOI: 10.1038/s41586-025-08671-2.


NFAT2 Induces Tumor Cell Proliferation and Metastasis by Acting as a Transcriptional Co-activator of the TGF-β1/SMAD Signaling Pathway and Inducing the Epithelial-Mesenchymal Transition in Liver Cancer.

Liu Y, Mo W, Sun W, Chen J, Chen J, Li Y Dig Dis Sci. 2025; .

PMID: 40038210 DOI: 10.1007/s10620-025-08890-7.


Decoding chromosomal instability insights in CRC by integrating omics and patient-derived organoids.

Papaccio F, Cabeza-Segura M, Garcia-Mico B, Gimeno-Valiente F, Zuniga-Trejos S, Gambardella V J Exp Clin Cancer Res. 2025; 44(1):77.

PMID: 40022181 PMC: 11869439. DOI: 10.1186/s13046-025-03308-8.


References
1.
Elenbaas B, Spirio L, Koerner F, Fleming M, Zimonjic D, Donaher J . Human breast cancer cells generated by oncogenic transformation of primary mammary epithelial cells. Genes Dev. 2001; 15(1):50-65. PMC: 312602. DOI: 10.1101/gad.828901. View

2.
Al-Hajj M, Wicha M, Benito-Hernandez A, Morrison S, Clarke M . Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci U S A. 2003; 100(7):3983-8. PMC: 153034. DOI: 10.1073/pnas.0530291100. View

3.
Shipitsin M, Campbell L, Argani P, Weremowicz S, Bloushtain-Qimron N, Yao J . Molecular definition of breast tumor heterogeneity. Cancer Cell. 2007; 11(3):259-73. DOI: 10.1016/j.ccr.2007.01.013. View

4.
Thiery J . Epithelial-mesenchymal transitions in development and pathologies. Curr Opin Cell Biol. 2003; 15(6):740-6. DOI: 10.1016/j.ceb.2003.10.006. View

5.
Liao M, Zhang C, Zhou B, Zimonjic D, Mani S, Kaba M . Enrichment of a population of mammary gland cells that form mammospheres and have in vivo repopulating activity. Cancer Res. 2007; 67(17):8131-8. DOI: 10.1158/0008-5472.CAN-06-4493. View